Form 4 for SCYX SCYNEXIS INC
Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-26 · accession 0000950170-24-008802 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-30 | 2024-01-26 | SCYX | Sukenick Scott | CLO | A - Grant | $0.00 | +143.7K | 351.4K | +69% | $0 |
| D | 2024-01-30 | 2024-01-26 | SCYX | Sukenick Scott | CLO | A - Grant | $0.00 | +215.5K | 215.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | A | A | 143,675 | $0.00 | 351,374 | D | — | — | (F1) Represents restricted stock units that vest one third per year over three years as measured from February 15, 2024. (F2) Includes 4,100 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2023 (100 shares) and September 2023 (4,000 shares). |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-01-26 | A | A | 215,515 | $0.00 | 215,515 | D | $1.86 · — to 2034-01-25 | 215,515 Common Stock | (F3) 1/48th of the shares subject to the option vest monthly for 48 months as measured from February 15, 2024. |